Eli Lilly enters multimillion-dollar settlement on US insulin prices
US-based pharmaceutical company Eli Lilly has got a million-dollar rap on knuckles for having overpriced its insulin products.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Eli Lilly’s CEO promises not to raise insulin prices
For subscribers
Sanofi follows Lilly, Novo in cutting insulin prices
For subscribers